FDA approves atezolizumab for BRAF V600 unresectable or metastatic melanoma

FDA approves atezolizumab for BRAF V600 unresectable or metastatic melanoma

Source: FDA Center for Drug Evaluation and Research - What's New - July 31, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news